Bookmark
Forward
Relevance of CYP2D6 for risperidone pharmacokinetics, pharmacodynamics and adverse reactions.
Adrián Llerena, Pedro Dorado, Eva M Peñas-Lledó
CICAB, Clinical Research Centre, Extremadura University Hospital & Medical School, Badajoz 06080, Spain. allerena@unex.es
Pharmacogenomics 2011 MarSizes of these terms reflect their relevance to your search.
No abstract available.
Citation
Adrián Llerena, Pedro Dorado, Eva M Peñas-Lledó. Relevance of CYP2D6 for risperidone pharmacokinetics, pharmacodynamics and adverse reactions. Pharmacogenomics. 2011 Mar;12(3):311-3
PMID: 21449670
View Full Text
